The promise and harms of screening for plasma cell dyscrasias.
Br J Haematol
; 200(6): 704-707, 2023 03.
Article
em En
| MEDLINE
| ID: mdl-36626939
ABSTRACT
In this perspective, we highlight both the promise and harms of screening for plasma cell dyscrasias, as well as the implications of the use of mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Paraproteinemias
/
Gamopatia Monoclonal de Significância Indeterminada
/
Mieloma Múltiplo
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article